ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 305802 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 305802; 2) Community: the network communities that were significantly associated with the response to NSC 305802; 3) Molecule: the relationships between components within communities and NSC 305802; 4) MDR: the compounds that were significantly associated with the NSC 305802.

NSC Compound Enrichment Correlation
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.022188614181866 0.37046133
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.022188614181866 0.67547184
NSC 18805 .gamma.-Thujaplicine 0.022188614181866 0.31252515
NSC 321491 Null 0.022188614181866 -0.33344729
NSC 339137 PHYSALOLACTONE 0.022188614181866 0.26345449
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.022188614181866 0.26396237
NSC 380856 ACRONYCINE, 2-NITRO 0.022188614181866 0.40076432
NSC 63878 Cytarabine Hydrochloride AZ 0.022188614181866 0.46283472
NSC 643836 Null 0.022188614181866 -0.23613357
NSC 645665 Null 0.022188614181866 0.44122816
Total:122  Current:69    [First] [Prev] [Next] [Last]